Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina L Porter

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Women'S Dermatology|October 8, 2021
Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infantRuby S Gibson, Martina L Porter, Alexa B Kimball
Expert Opinion on Drug Safety|April 29, 2021
A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needsZachary E Holcomb, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|August 31, 2018
Online communications among hidradenitis suppurativa patients reflect community needsNicole M Golbari, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|September 17, 2019
Nonmelanoma skin cancers are more likely to be untreated in elderly patientsPallavi Basu, Ashley Beckles, Martina L Porter, et al.
Cutis|May 3, 2018
Current guidelines for psoriasis treatment: a work in progressNicole M Golbari, Martina L Porter, Alexa B Kimball
International Journal of Women'S Dermatology|August 22, 2024
Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trialsSimon J Gunter, Martina L Porter, Alexa B Kimball
International Journal of Women'S Dermatology|May 12, 2017
Update on biologic safety for patients with psoriasis during pregnancyMartina L Porter, Stephen J Lockwood, Alexa B Kimball
JAAD International|May 27, 2022
Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativaRuby S Gibson, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|October 3, 2020
A visit guide for hidradenitis suppurativa-Managing a complex disease in a busy clinicKelsey S Flood, Martina L Porter, Alexa B Kimball
American Journal of Clinical Dermatology|May 30, 2019
Biologic Treatment for Hidradenitis SuppurativaKelsey S Flood, Martina L Porter, Alexa B Kimball
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Women'S Dermatology|October 8, 2021
Response to Letter to the Editor entitled: Rethinking biologic and pregnancy research: The importance of assessing postpartum immunosuppression of the infantRuby S Gibson, Martina L Porter, Alexa B Kimball
Expert Opinion on Drug Safety|April 29, 2021
A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needsZachary E Holcomb, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|August 31, 2018
Online communications among hidradenitis suppurativa patients reflect community needsNicole M Golbari, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|September 17, 2019
Nonmelanoma skin cancers are more likely to be untreated in elderly patientsPallavi Basu, Ashley Beckles, Martina L Porter, et al.
Cutis|May 3, 2018
Current guidelines for psoriasis treatment: a work in progressNicole M Golbari, Martina L Porter, Alexa B Kimball
International Journal of Women'S Dermatology|August 22, 2024
Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trialsSimon J Gunter, Martina L Porter, Alexa B Kimball
International Journal of Women'S Dermatology|May 12, 2017
Update on biologic safety for patients with psoriasis during pregnancyMartina L Porter, Stephen J Lockwood, Alexa B Kimball
JAAD International|May 27, 2022
Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativaRuby S Gibson, Martina L Porter, Alexa B Kimball
Journal of the American Academy of Dermatology|October 3, 2020
A visit guide for hidradenitis suppurativa-Managing a complex disease in a busy clinicKelsey S Flood, Martina L Porter, Alexa B Kimball
American Journal of Clinical Dermatology|May 30, 2019
Biologic Treatment for Hidradenitis SuppurativaKelsey S Flood, Martina L Porter, Alexa B Kimball
Pageof 7